Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma-Reference-Cited by-同舟云学术

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma

Published:2021-05 Issue:5 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Shi Zhiwen¹,Zhao Qingguo²,Lv Bin¹,Qu Xinyu¹,Han Xiao²,Wang Hongyan¹,Qiu Junjun¹³,Hua Keqin¹³

Affiliation:

1. Obstetrics and Gynecology Hospital Fudan University Shanghai China

2. State Key Laboratory of Genetic Engineering, MOE Key Laboratory of Contemporary Anthropology, and Collaborative Innovation Center for Genetics & Development, School of Life Sciences Fudan University Shanghai China

3. Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Shanghai China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.399

Reference50 articles.

1. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence

2. Diagnosis of ovarian cancer

3. Network vulnerability‐based and knowledge‐guided identification of microRNA biomarkers indicating platinum resistance in high‐grade serous ovarian cancer;Qi X;Clin Transl Med,2019

4. Five‐year relative survival rate of ovarian cancer in the USA, Europe and Japan;Matsuda A;Jpn J Clin Oncol,2014

5. Homologous recombination in DNA repair and DNA damage tolerance

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning for the identification of neoantigen-reactive CD8 + T cells in gastrointestinal cancer using single-cell sequencing;British Journal of Cancer;2024-06-07

2. Primary Serous Cystadenocarcinoma of the Spleen;Cureus;2024-02-28

3. Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor;Journal of Natural Products;2024-02-28

4. Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer;Japanese Journal of Clinical Oncology;2024-02-01

5. Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma;Experimental and Therapeutic Medicine;2023-07-21